Adriamycin

Details:

Year Establishment: 2009

Location: 18-1-802, Green Garden, Jianghan District, Wuhan 430023, China

Main product:
- API:Antiobesity; Oncology; Antiviral; Cardiovascular; Antibiotics; Antidiabetics and others
- Peptides
- Hormones
- Intermediates

Specifications: Adriamycin(CAS: 23214-92-8)

Name:  Adriamycin

Synonyms: 10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione; 14-Hydroxydaunomycin; (8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione; adiblastine (hydrochloride salt); adriablastine (hydrochloride salt); adriablatina (hydrochloride salt); Adriacin; Adriacin (hydrochloride salt); Adriamycin PFS; Adriamycin PFS (hydrochloride salt); Adriamycin RDF; Adriamycin RDF (hydrochloride salt); Adriblastin; Adriblastina; Adriblastina (hydrochloride salt); adriblatina (hydrochloride salt); Doxorubicin; Doxorubicin hydrochloride (hydrochloride salt); Farmablastina (hydrochloride salt); Hydroxydaunomycin hydrochloride (hydrochloride salt); Hydroxydaunorubicin hydrochloride (hydrochloride salt); Rubex; Rubex (hydrochloride salt); (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
Molecular Formula: C27H30ClNO10

Molecular Weight: 543.5193

CAS Registry Number:  23214-92-8

EINECS: 245-495-6

Delivery Time: Within 4 weeks after payment

Uses: Clinical application in the treatment of acute and chronic lymphocytic leukemia and solid tumors.The adverse reactions of this product include marrow inhibition of myocardial toxicity.

Our Factory: